![](/img/cover-not-exists.png)
PSN2 COST-EFFECTIVENESS ANALYSIS: ALDARA™ (IMIQUIMOD) CREAM, 5% IN THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA IN NORWAY
JM Sverre, FKO Kristensen, L Hamel-Gariépy, T AlbrektsenVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67587-0
File:
PDF, 61 KB
english, 2005